<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the incidence of post-transplant <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> in a cohort of 109 patients who had undergone auto-peripheral blood stem cell transplantation (PBSCT) for <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (n = 18), <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (n = 7), non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 52), <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (n = 5), <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (n = 16), <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (n = 1), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (n = 3) and <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> (n = 7) </plain></SENT>
<SENT sid="1" pm="."><plain>The patients were followed up for a median of 32 months after PBSCT </plain></SENT>
<SENT sid="2" pm="."><plain>Five second solid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> developed in 4 patients within 14 to 43 months after PBSCT: large cell <z:mp ids='MP_0002038'>carcinoma</z:mp> of the lung, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the rectum, cholangiocellular <z:mp ids='MP_0002038'>carcinoma</z:mp> of the liver, <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> of the mouth, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the gallbladder </plain></SENT>
<SENT sid="3" pm="."><plain>The affected patients were 3 of 52 with non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and one of 16 with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>One of the patients was in the 5th decade of life (n = 31) and 3 were in the 6th decade (n = 31) </plain></SENT>
<SENT sid="5" pm="."><plain>The cumulative actuarial risk for developing post-transplant <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> was 8% at 8 years </plain></SENT>
<SENT sid="6" pm="."><plain>Elderly patients (&gt; or = 60 year old) who have undergone PBSCT need to be observed carefully for second <z:hpo ids='HP_0002664'>neoplasms</z:hpo> because of their increased risk of post-transplant <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
</text></document>